{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:39:19Z","timestamp":1791567559959,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.prostaglandins.2024.106934","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T18:38:31Z","timestamp":1731177511000},"page":"106934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Does glucomannan supplementation exert profitable effects on serum lipid profile in adults? A systematic review and meta-analysis"],"prefix":"10.1016","volume":"176","author":[{"given":"Zhu","family":"Haijun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Dawei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Haedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elika","family":"Poorasadollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010363","article-title":"Dyslipidemia and cardiovascular disease: current knowledge, existing challenges, and new opportunities for management strategies","volume":"12","author":"Du","year":"2023","journal-title":"J. Clin. Med"},{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12944-020-01204-y","article-title":"Dyslipidemia and cardiovascular disease risk among the MASHAD study population","volume":"19","author":"Hedayatnia","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib3","doi-asserted-by":"crossref","first-page":"8300428","DOI":"10.1155\/2024\/8300428","article-title":"Herbal products as complementary or alternative medicine for the management of hyperglycemia and dyslipidemia in patients with type 2 diabetes: current evidence based on findings of interventional studies","volume":"2024","author":"Farhadnejad","year":"2024","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.prostaglandins.2024.106934_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2024.106108","article-title":"Konjac Glucomannan: a functional food additive for preventing metabolic syndrome","volume":"115","author":"Jian","year":"2024","journal-title":"J. Funct. Foods"},{"issue":"7","key":"10.1016\/j.prostaglandins.2024.106934_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072191","article-title":"Konjac glucomannan attenuated triglyceride metabolism during rice gruel tolerance test","volume":"13","author":"Nagasawa","year":"2021","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.prostaglandins.2024.106934_bib6","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/jn\/130.11.2753","article-title":"Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats","volume":"130","author":"Gallaher","year":"2000","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.metabol.2006.08.021","article-title":"Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk","volume":"56","author":"Wood","year":"2007","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/07315724.2003.10719273","article-title":"Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects\u2014a randomized double-blind trial","volume":"22","author":"Chen","year":"2003","journal-title":"J. Am. Coll. Nutr."},{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09528954.1987.11904101","article-title":"The effects of the dietary fibre component konjac-glucomannan on serum cholesterol levels of hypercholesterolaemic subjects","volume":"41","author":"Venter","year":"1987","journal-title":"Hum. Nutr. Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diacare.23.1.9","article-title":"Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial","volume":"23","author":"Vuksan","year":"2000","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.prostaglandins.2024.106934_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2337\/diacare.22.6.913","article-title":"Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial","volume":"22","author":"Vuksan","year":"1999","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.prostaglandins.2024.106934_bib12","first-page":"2150","article-title":"Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus","volume":"90","author":"Chearskul","year":"2007","journal-title":"Med. J. Med. Assoc. Thail."},{"issue":"4","key":"10.1016\/j.prostaglandins.2024.106934_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ajcn\/88.4.1167","article-title":"Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis","volume":"88","author":"Sood","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.prostaglandins.2024.106934_bib14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3945\/ajcn.116.142158","article-title":"A systematic review and meta-analysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B","volume":"105","author":"Ho","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.prostaglandins.2024.106934_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.prostaglandins.2024.106934_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.prostaglandins.2024.106934_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.prostaglandins.2024.106934_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/ajcn\/61.3.585","article-title":"Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men","volume":"61","author":"Arvill","year":"1995","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"10.1016\/j.prostaglandins.2024.106934_bib19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1017\/S0007114511001711","article-title":"Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals","volume":"106","author":"Vuksan","year":"2011","journal-title":"Br. J. Nutr."},{"issue":"4","key":"10.1016\/j.prostaglandins.2024.106934_bib20","first-page":"289","article-title":"Effect of glucomannan on obese patients: a clinical study","volume":"8","author":"Walsh","year":"1984","journal-title":"Int J. Obes."},{"issue":"4","key":"10.1016\/j.prostaglandins.2024.106934_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.ejcn.1602347","article-title":"Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes","volume":"60","author":"Yoshida","year":"2006","journal-title":"Eur. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.prostaglandins.2024.106934_bib22","first-page":"505","article-title":"Beneficial effects of konjac powder on lipid profile in schizophrenia with dyslipidemia: a randomized controlled trial","volume":"29","author":"Zhang","year":"2020","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"7404","key":"10.1016\/j.prostaglandins.2024.106934_bib23","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"25__2","key":"10.1016\/j.prostaglandins.2024.106934_bib24","first-page":"S1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.prostaglandins.2024.106934_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072056","article-title":"Diet and nutraceutical supplementation in dyslipidemic patients: first results of an italian single center real-world retrospective analysis","volume":"12","author":"Pasta","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib26","article-title":"Treatment strategy for dyslipidemia in cardiovascular disease prevention: focus on old and new drugs","volume":"6","author":"Zodda","year":"2018","journal-title":"Pharm. (Basel)"},{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12944-017-0460-3","article-title":"Effects of 3 g of soluble fiber from oats on lipid levels of Asian Indians - a randomized controlled, parallel arm study","volume":"16","author":"Gulati","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"12","key":"10.1016\/j.prostaglandins.2024.106934_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11883-016-0624-z","article-title":"Lipid lowering with soluble dietary fiber","volume":"18","author":"Surampudi","year":"2016","journal-title":"Curr. Atheroscler. Rep."},{"issue":"1","key":"10.1016\/j.prostaglandins.2024.106934_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ajcn\/69.1.30","article-title":"Cholesterol-lowering effects of dietary fiber: a meta-analysis*","volume":"69","author":"Brown","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.prostaglandins.2024.106934_bib30","first-page":"154","article-title":"Cholesterol and cardiovascular disease in the elderly. Facts and gaps","volume":"4","author":"F\u00e9lix-Redondo","year":"2013","journal-title":"Aging Dis."},{"issue":"12","key":"10.1016\/j.prostaglandins.2024.106934_bib31","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/nu2121266","article-title":"Effects of dietary fiber and its components on metabolic health","volume":"2","author":"Lattimer","year":"2010","journal-title":"Nutrients"},{"key":"10.1016\/j.prostaglandins.2024.106934_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.fochx.2024.101610","article-title":"Fecal fermentation behaviors of Konjac glucomannan and its impacts on human gut microbiota","volume":"23","author":"Tan","year":"2024","journal-title":"Food Chem. X"},{"issue":"9","key":"10.1016\/j.prostaglandins.2024.106934_bib33","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J. Lipid Res"},{"key":"10.1016\/j.prostaglandins.2024.106934_bib34","article-title":"The starch-rich diet causes lipidemia while the fat-rich diet induces visceral adiposity, meta-inflammation, and insulin resistance differentially in immune biased mouse strains, Food","volume":"42","author":"Mukherjee","year":"2021","journal-title":"Bioscience"},{"key":"10.1016\/j.prostaglandins.2024.106934_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clnesp.2021.01.033","article-title":"Weight loss and its influence on high-density lipoprotein cholesterol (HDL-C) concentrations: a noble clinical hesitation","volume":"42","author":"Santos","year":"2021","journal-title":"Clin. Nutr. ESPEN"},{"issue":"2(2)","key":"10.1016\/j.prostaglandins.2024.106934_bib36","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.2337\/dc09-S355","article-title":"Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration","volume":"32","author":"Staels","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.prostaglandins.2024.106934_bib37","doi-asserted-by":"crossref","first-page":"1143682","DOI":"10.3389\/fnut.2023.1143682","article-title":"\u03b2-glucans: a potential source for maintaining gut microbiota and the immune system","volume":"10","author":"Singh","year":"2023","journal-title":"Front Nutr."},{"issue":"6","key":"10.1016\/j.prostaglandins.2024.106934_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1054\/mehy.2001.1457","article-title":"Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapy","volume":"58","author":"McCarty","year":"2002","journal-title":"Med. Hypotheses"}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109888232400128X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109888232400128X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T21:56:36Z","timestamp":1737323796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109888232400128X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"alternative-id":["S109888232400128X"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2024.106934","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does glucomannan supplementation exert profitable effects on serum lipid profile in adults? A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2024.106934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106934"}}